Completed PHASE4 INTERVENTIONAL 2-arm NCT02550093

The Effect of Intranasal Oxytocin on Pain Sensitivity and Threshold

The Effect of Intranasal Oxytocin on Pain Sensitivity and Threshold: A Randomized, Double Blinded, Crossover Volunteer Study

Sponsor: Northwestern University

Conditions Healthy

Interventions Intervention 1 Intervention 2 Washout Period

Updated 7 times since 2017 Last updated: May 12, 2022 Started: Apr 30, 2015 Primary completion: Aug 31, 2015 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Healthy and is currently completed. Northwestern University leads this study, which shows 7 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jun 2022 — Jul 2024 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jan 2021 — Jun 2022 [monthly]

Unknown Status PHASE4
Oct 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Active Not Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Oct 2018 [monthly]

Active Not Recruiting PHASE4
Jan 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE4

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Northwestern University

Data source: Northwestern University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States